Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Veru Inc. (VERU)

  • Technical Exchange News
  • April 10, 2024, 22:02 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient and Delinquent. New value: Deficient.

Comment Full text

Iterum Therapeutics plc (ITRM)

  • Technical Exchange News
  • April 10, 2024, 22:01 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Imunon Inc (IMNN)

  • Technical Exchange News
  • April 10, 2024, 22:01 UTC
  • 34
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Eiger BioPharmaceuticals Inc (EIGR)

  • Technical Exchange News
  • April 10, 2024, 22:01 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient and Bankrupt. New value: Normal.

Comment Full text

Acorda Therapeutics Inc. (ACOR)

  • Technical Exchange News
  • April 10, 2024, 22:00 UTC
  • 35
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient and Bankrupt.

Comment Full text

Viracta Therapeutics Inc (VIRX)

  • Technical Exchange News
  • April 10, 2024, 01:59 UTC
  • 28
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Virpax Pharmaceuticals Inc (VRPX)

  • Technical Exchange News
  • April 10, 2024, 01:59 UTC
  • 33
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Meihua International Medical Technologies Co Ltd (MHUA)

  • Technical Exchange News
  • April 10, 2024, 01:59 UTC
  • 27
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Luna Innovations Incorporated (LUNA)

  • Technical Exchange News
  • April 10, 2024, 01:59 UTC
  • 29
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

Moleculin Biotech Inc. (MBRX)

  • Technical Exchange News
  • April 10, 2024, 01:59 UTC
  • 30
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 713
  • 714
  • 715
  • 716
  • 717
  • Next

Search

News categories

  • Technical Exchange News(11854)
  • Event(4571)
  • SEC News(240113)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(145541)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin